NCT01250509

Brief Summary

The purpose of this study is to determine whether a mindfulness-based stress reduction and mindful eating program will lead to reductions in abdominal fat and total weight and improve cell aging in overweight and obese women compared to a waitlist control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for phase_2 obesity

Timeline
Completed

Started Nov 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2006

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2007

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

November 23, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 30, 2010

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

February 18, 2013

Completed
Last Updated

February 18, 2013

Status Verified

January 1, 2013

Enrollment Period

11 months

First QC Date

November 23, 2010

Results QC Date

May 29, 2012

Last Update Submit

January 16, 2013

Conditions

Keywords

ObesityMindfulness based stress reductionMindful eatingStressOvernutritionNutrition DisordersOverweightBody WeightSigns and Symptoms

Outcome Measures

Primary Outcomes (1)

  • Change in Abdominal Fat

    Whole-body dual energy X-ray absorptiometry (DEXA) scans were performed to assess body fat distribution. The DEXA densitometry (GE Healthcare Lunar Prodigy, Madison, Wis, USA) was adjusted to the fan beam mode and EnCore software version 9.15 was used. The primary region of interest was fat tissue from a rectangular region in the abdominal area defined by the upper boundary of the second lumbar vertebra to the lower edge of the fourth lumbar vertebra. The vertical sides were defined as the continuation of the lateral sides of the rib cage.

    Change from Baseline in Abdominal Fat (baseline and 4 months)

Secondary Outcomes (3)

  • Weight

    Change in Weight (baseline and 4 months)

  • Telomerase Activity

    Change from Baseline in Telomerase Activity at 4 months

  • Change in Psychological Stress (Baseline and 4 Months)

    Change from Baseline in Psychological Stress

Study Arms (2)

CALMM

EXPERIMENTAL

Participants receiving the 'Craving and Lifestyle Management through Mindfulness' intervention, i.e. program that combines stress reduction with mindful eating practices.

Behavioral: Craving and Lifestyle Management through Mindfulness

Waitlist Control

NO INTERVENTION

Participants were waitlisted for the intervention during the experimental phase.

Interventions

A preliminary, novel intervention was developed drawing on components from Mindfulness-Based Stress Reduction (MBSR), Mindfulness-Based Cognitive Therapy (MBCT), and Mindfulness-Based Eating Awareness Training (MB-EAT). The intervention program consisted of nine 2.5-hour classes and one 7-hour silent day of guided meditation practice after class 6.

CALMM

Eligibility Criteria

Age21 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pre-menopausal
  • BMI (25 - 40)
  • Weight \< 300 lbs.
  • Negative urine glucose test

You may not qualify if:

  • Inability to provide informed consent
  • Age \< 21 or menopausal as determined by self-report
  • DSM-IV diagnosis of an eating disorder
  • Any substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the intervention
  • Factors that confound relations between stress and eating, including, drug abuse and use of medications containing corticosteroids.
  • Diabetes
  • Polycystic Ovary Syndrome
  • CHD
  • Breastfeeding (due to interference with stress hormone measurement)
  • Non English speaker
  • Pregnant as determined by pregnancy test at screening visit or planning to get pregnant in the next 6 months
  • Previous MBSR training and/or current meditation, yoga, or other mind-body practice
  • Initiation of new class of psychiatric medications in past 2 months.
  • Currently on a weight loss diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Osher Center for Integrative Medicine

San Francisco, California, 94115, United States

Location

Related Publications (11)

  • Baer RA, Smith GT, Allen KB. Assessment of mindfulness by self-report: the Kentucky inventory of mindfulness skills. Assessment. 2004 Sep;11(3):191-206. doi: 10.1177/1073191104268029.

    PMID: 15358875BACKGROUND
  • Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002 Oct 9;288(14):1723-7. doi: 10.1001/jama.288.14.1723.

    PMID: 12365955BACKGROUND
  • Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, Bell J, Ickovics JR. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000 Sep-Oct;62(5):623-32. doi: 10.1097/00006842-200009000-00005.

    PMID: 11020091BACKGROUND
  • Oliver G, Wardle J, Gibson EL. Stress and food choice: a laboratory study. Psychosom Med. 2000 Nov-Dec;62(6):853-65. doi: 10.1097/00006842-200011000-00016.

    PMID: 11139006BACKGROUND
  • Boggiano MM, Chandler PC, Viana JB, Oswald KD, Maldonado CR, Wauford PK. Combined dieting and stress evoke exaggerated responses to opioids in binge-eating rats. Behav Neurosci. 2005 Oct;119(5):1207-14. doi: 10.1037/0735-7044.119.5.1207.

    PMID: 16300427BACKGROUND
  • Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005 Nov 5;366(9497):1640-9. doi: 10.1016/S0140-6736(05)67663-5.

    PMID: 16271645BACKGROUND
  • Epel E, Lapidus R, McEwen B, Brownell K. Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001 Jan;26(1):37-49. doi: 10.1016/s0306-4530(00)00035-4.

    PMID: 11070333BACKGROUND
  • Epel E, Jimenez S, Brownell K, Stroud L, Stoney C, Niaura R. Are stress eaters at risk for the metabolic syndrome? Ann N Y Acad Sci. 2004 Dec;1032:208-10. doi: 10.1196/annals.1314.022.

    PMID: 15677412BACKGROUND
  • Rebuffe-Scrive M, Walsh UA, McEwen B, Rodin J. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism. Physiol Behav. 1992 Sep;52(3):583-90. doi: 10.1016/0031-9384(92)90351-2.

    PMID: 1409924BACKGROUND
  • Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005 Jan;30(1):1-10. doi: 10.1016/j.psyneuen.2004.05.007.

    PMID: 15358437BACKGROUND
  • Roemmich JN, Wright SM, Epstein LH. Dietary restraint and stress-induced snacking in youth. Obes Res. 2002 Nov;10(11):1120-6. doi: 10.1038/oby.2002.152.

    PMID: 12429875BACKGROUND

MeSH Terms

Conditions

ObesityOvernutritionNutrition DisordersOverweightBody WeightSigns and Symptoms

Condition Hierarchy (Ancestors)

Nutritional and Metabolic DiseasesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Jennifer Daubenmier, PhD
Organization
University of California, San Francisco

Study Officials

  • Elissa Epel, PhD

    UCSF Department of Psychiatry

    PRINCIPAL INVESTIGATOR
  • Frederick Hecht, MD

    UCSF Osher Center for Integrative Medicine

    PRINCIPAL INVESTIGATOR
  • Jennifer Daubenmier, PhD

    UCSF Osher Center for Integrative Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2010

First Posted

November 30, 2010

Study Start

November 1, 2006

Primary Completion

October 1, 2007

Study Completion

July 1, 2008

Last Updated

February 18, 2013

Results First Posted

February 18, 2013

Record last verified: 2013-01

Locations